Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-24-005323
Filing Date
2024-01-22
Accepted
2024-01-19 21:57:15
Documents
20

Document Format Files

Seq Description Document Type Size
1 424B4 tm2333928-9_424b4.htm 424B4 3377637
2 GRAPHIC lg_transcodetheraptm-4c.jpg GRAPHIC 10029
3 GRAPHIC fc_therapeutics-4clr.jpg GRAPHIC 43890
4 GRAPHIC fc_currentpipeline-4clr.jpg GRAPHIC 36178
5 GRAPHIC fc_therapeutic-4clr.jpg GRAPHIC 61918
6 GRAPHIC fc_figure1-4clr.jpg GRAPHIC 95689
7 GRAPHIC fc_figure2-4clr.jpg GRAPHIC 46593
8 GRAPHIC fc_figure3-4clr.jpg GRAPHIC 215554
9 GRAPHIC fc_figure4-4clr.jpg GRAPHIC 122582
10 GRAPHIC fc_figure5-4clr.jpg GRAPHIC 113202
11 GRAPHIC fc_figure6-4clr.jpg GRAPHIC 69097
12 GRAPHIC fc_figure7-4clr.jpg GRAPHIC 51321
13 GRAPHIC fc_figure8-4clr.jpg GRAPHIC 95523
14 GRAPHIC lc_figure9-4clr.jpg GRAPHIC 70189
15 GRAPHIC lc_figure10-4clr.jpg GRAPHIC 60635
16 GRAPHIC fc_figure11-4clr.jpg GRAPHIC 78170
17 GRAPHIC lc_figure12-4clr.jpg GRAPHIC 53778
18 GRAPHIC fc_figure13-4clr.jpg GRAPHIC 66940
19 GRAPHIC fc_figure14-4clr.jpg GRAPHIC 102884
20 GRAPHIC lc_figure15-4clr.jpg GRAPHIC 30770
  Complete submission text file 0001104659-24-005323.txt   5342877
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-276467 | Film No.: 24546954
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)